Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +2.59% | +15.88% | -34.55% |
May. 15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
May. 14 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
Financials (USD)
Sales 2024 * | 73.92M | Sales 2025 * | 126M | Capitalization | 37.12M |
---|---|---|---|---|---|
Net income 2024 * | -89M | Net income 2025 * | -75M | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.29 x |
P/E ratio 2024 * |
-0.41
x | P/E ratio 2025 * |
-0.6
x | Employees | 186 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.59% |
1 day | +9.66% | ||
1 week | +15.57% | ||
Current month | +15.57% | ||
1 month | +10.29% | ||
3 months | +3.76% | ||
6 months | -7.66% | ||
Current year | -35.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 09-09-30 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Weiss
BRD | Director/Board Member | 58 | 13-12-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 09-09-30 | |
Michael Weiss
BRD | Director/Board Member | 58 | 13-12-19 |
J. Lobell
BRD | Director/Board Member | 61 | 06-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 1.98 | +2.59% | 188 711 |
24-05-17 | 1.93 | +9.66% | 334,417 |
24-05-16 | 1.76 | +1.15% | 164,078 |
24-05-15 | 1.74 | -1.14% | 102,275 |
24-05-14 | 1.76 | +3.53% | 172,016 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.88% | 37.12M | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+60.08% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+5.09% | 8.79B |
- Stock Market
- Equities
- FBIO Stock